SESN2 and lung carcinoma: Additionally, SESN2 knockdown attenuated the proliferation and migration of lung cancer cells as well as enhancing the cytotoxic effects of ROS-inducing chemotherapeutic drugs (doxorubicin and cisplatin) [22].